Andrew Perry

Corporate Officer/Principal at G1 THERAPEUTICS, INC.

Net worth: 256 760 $ as of 2024-06-29

51 year

Consumer Services

Health Technology

Profile

Andrew Perry is currently the Chief Commercial Officer at G1 Therapeutics, Inc. He previously worked as the Vice President of US Marketing at ViiV Healthcare Ltd.
Mr. Perry is a graduate of the University of Glasgow and The University of Sheffield.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
G1 THERAPEUTICS, INC. 0.22%	2024-07-04	112,614 ( 0.22% )	256 760 $	2024-06-29

Andrew Perry active positions

Companies	Position	Start
G1 THERAPEUTICS, INC.	Corporate Officer/Principal	2021-08-01

All active positions of Andrew Perry

Former positions of Andrew Perry

Companies	Position	End
ViiV Healthcare Ltd. ViiV Healthcare Ltd. Pharmaceuticals: MajorHealth Technology ViiV Healthcare Ltd. manufactures and distributes pharmaceutical products. Its medicine include Triumeq, Tivicay, Selzentry, Celesentri, Epzicom, Kivexa, Ziagen, Trizivir, Combivir, Retrovir AZT, Lexiva, Telzir, Viracept and Rescriptor. The company was founded in 2009 and is headquartered in Brentford, the United Kingdom.	Corporate Officer/Principal	-

See the detail of Andrew Perry's experience

Training of Andrew Perry

University of Glasgow	Graduate Degree
The University of Sheffield	Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Andrew Perry's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
G1 THERAPEUTICS, INC.	Health Technology

Private companies	1
ViiV Healthcare Ltd. ViiV Healthcare Ltd. Pharmaceuticals: MajorHealth Technology ViiV Healthcare Ltd. manufactures and distributes pharmaceutical products. Its medicine include Triumeq, Tivicay, Selzentry, Celesentri, Epzicom, Kivexa, Ziagen, Trizivir, Combivir, Retrovir AZT, Lexiva, Telzir, Viracept and Rescriptor. The company was founded in 2009 and is headquartered in Brentford, the United Kingdom.	Health Technology